BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9165626)

  • 1. Emptying against outflow obstruction--pharmacological aspects.
    Andersson KE
    Scand J Urol Nephrol Suppl; 1997; 184():77-84. PubMed ID: 9165626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Function of M3 muscarinic receptors in the rat urinary bladder following partial outlet obstruction.
    Krichevsky VP; Pagala MK; Vaydovsky I; Damer V; Wise GJ
    J Urol; 1999 May; 161(5):1644-50. PubMed ID: 10210432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of a type 4 phosphodiesterase inhibitor and the muscarinic cholinergic antagonist tolterodine tartrate on detrusor overactivity in female rats with bladder outlet obstruction.
    Kaiho Y; Nishiguchi J; Kwon DD; Chancellor MB; Arai Y; Snyder PB; Yoshimura N
    BJU Int; 2008 Mar; 101(5):615-20. PubMed ID: 18070178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obstruction alters muscarinic receptor-coupled RhoA/Rho-kinase pathway in the urinary bladder of the rat.
    Takahashi N; Shiomi H; Kushida N; Liu F; Ishibashi K; Yanagida T; Shishido K; Aikawa K; Yamaguchi O
    Neurourol Urodyn; 2009; 28(3):257-62. PubMed ID: 19229948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment-resistant detrusor overactivity--underlying pharmacology and potential mechanisms.
    Andersson KE
    Int J Clin Pract Suppl; 2006 Dec; (151):8-16. PubMed ID: 17169005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and experimental aspects of Adreno-muscarinic synergy in the bladder base and prostate.
    Roosen A; Blake-James BT; Wood D; Fry CH
    Neurourol Urodyn; 2009; 28(8):938-43. PubMed ID: 19618452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscarinic receptor antagonists for overactive bladder.
    Abrams P; Andersson KE
    BJU Int; 2007 Nov; 100(5):987-1006. PubMed ID: 17922784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ca2+ regulation in detrusor smooth muscle from ovine fetal bladder after in utero bladder outflow obstruction.
    Wu C; Thiruchelvam N; Sui G; Woolf AS; Cuckow P; Fry CH
    J Urol; 2007 Feb; 177(2):776-80. PubMed ID: 17222680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterization of urinary bladder smooth muscle contractility following partial bladder outlet obstruction in pigs.
    Milicic I; Buckner SA; Daza A; Coghlan M; Fey TA; Brune ME; Gopalakrishnan M
    Eur J Pharmacol; 2006 Feb; 532(1-2):107-14. PubMed ID: 16487510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in purinergic and cholinergic components of contractile responses of isolated detrusor contraction in a rat model of partial bladder outlet obstruction.
    Banks FC; Knight GE; Calvert RC; Morgan RJ; Burnstock G
    BJU Int; 2006 Feb; 97(2):372-8. PubMed ID: 16430650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of potassium channel modulators on human detrusor smooth muscle myogenic phasic contractile activity: potential therapeutic targets for overactive bladder.
    Darblade B; Behr-Roussel D; Oger S; Hieble JP; Lebret T; Gorny D; Benoit G; Alexandre L; Giuliano F
    Urology; 2006 Aug; 68(2):442-8. PubMed ID: 16904481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of detrusor dysfunction in the elderly: changes in acetylcholine and adenosine triphosphate release during aging.
    Yoshida M; Miyamae K; Iwashita H; Otani M; Inadome A
    Urology; 2004 Mar; 63(3 Suppl 1):17-23. PubMed ID: 15013648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased contractile response to phenylephrine in detrusor of patients with bladder outlet obstruction: effect of the alpha1A and alpha1D-adrenergic receptor antagonist tamsulosin.
    Bouchelouche K; Andersen L; Alvarez S; Nordling J; Bouchelouche P
    J Urol; 2005 Feb; 173(2):657-61. PubMed ID: 15643283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration in contractile responses in human detrusor smooth muscle from obstructed bladders with overactivity.
    Kosan M; Tul M; Ozturk B; Hafez G; Inal G; Cetinkaya M
    Urol Int; 2008; 80(2):193-200. PubMed ID: 18362492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimuscarinic drug inhibits detrusor overactivity induced by topical application of prostaglandin E2 to the urethra with a decrease in urethral pressure.
    Yokoyama O; Miwa Y; Oyama N; Aoki Y; Ito H; Akino H
    J Urol; 2007 Nov; 178(5):2208-12. PubMed ID: 17870108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional differences in responses of rabbit detrusor to electrical and adrenergic stimulation: influence of outlet obstruction.
    Capello SA; Chieh-Lung Chou E; Longhurst PA
    BJU Int; 2005 Jan; 95(1):157-62. PubMed ID: 15638915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of bladder function by peripheral nerves: avenues for novel drug targets.
    Fry CH; Ikeda Y; Harvey R; Wu C; Sui GP
    Urology; 2004 Mar; 63(3 Suppl 1):24-31. PubMed ID: 15013649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detrusor contraction duration as a urodynamic parameter of bladder outlet obstruction for evaluating men with lower urinary tract symptoms.
    Ameda K; Steele GS; Sullivan MP; Stember D; Yalla SV
    J Urol; 1998 Aug; 160(2):482-6. PubMed ID: 9679903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscarinic receptor subtypes in the lower urinary tract.
    Giglio D; Tobin G
    Pharmacology; 2009; 83(5):259-69. PubMed ID: 19295256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiology and pharmacology of the human ureter: basis for current and future treatments.
    Canda AE; Turna B; Cinar GM; Nazli O
    Urol Int; 2007; 78(4):289-98. PubMed ID: 17495484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.